JP2005510211A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005510211A5 JP2005510211A5 JP2003526952A JP2003526952A JP2005510211A5 JP 2005510211 A5 JP2005510211 A5 JP 2005510211A5 JP 2003526952 A JP2003526952 A JP 2003526952A JP 2003526952 A JP2003526952 A JP 2003526952A JP 2005510211 A5 JP2005510211 A5 JP 2005510211A5
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- protein
- composition
- pharmaceutical composition
- introducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101710125507 Integrase/recombinase Proteins 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 230000036039 immunity Effects 0.000 claims 8
- 208000005176 Hepatitis C Diseases 0.000 claims 6
- 230000001684 chronic effect Effects 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 4
- 229960005486 vaccine Drugs 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14544001A IL145440A0 (en) | 2001-09-13 | 2001-09-13 | Synthetic hcv envelope proteins and their use for vaccination |
| PCT/IL2002/000744 WO2003022880A2 (en) | 2001-09-13 | 2002-09-09 | Synthetic hcv envelope proteins and their use for vaccination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005510211A JP2005510211A (ja) | 2005-04-21 |
| JP2005510211A5 true JP2005510211A5 (https=) | 2006-01-05 |
Family
ID=11075784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526952A Abandoned JP2005510211A (ja) | 2001-09-13 | 2002-09-09 | 合成ｈｃｖ外被蛋白質及びワクチンのためのその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050069865A1 (https=) |
| EP (1) | EP1427827A2 (https=) |
| JP (1) | JP2005510211A (https=) |
| KR (1) | KR20040041612A (https=) |
| CN (1) | CN1555415A (https=) |
| CA (1) | CA2460509A1 (https=) |
| IL (1) | IL145440A0 (https=) |
| WO (1) | WO2003022880A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1846439A2 (en) * | 2005-01-31 | 2007-10-24 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| EP2061805B1 (en) | 2006-08-25 | 2020-02-12 | Macfarlane Burnet Institute for Medical Research and Public Health Limited | Recombinant hcv e2 glycoprotein |
| US9758794B2 (en) * | 2008-04-22 | 2017-09-12 | Rutgers, The State University Of New Jersey | HCV E2 construct compositions and methods |
| WO2009146902A1 (en) * | 2008-06-03 | 2009-12-10 | Okairòs Ag | A vaccine for the prevention and therapy of hcv infections |
| US9512184B2 (en) | 2011-05-20 | 2016-12-06 | Emory University | Hepatitis C virus particles, vaccines, compositions and methods related thereto |
| CN105330730A (zh) * | 2014-07-29 | 2016-02-17 | 中国科学院上海巴斯德研究所 | 一种丙型肝炎病毒重组蛋白的制备及其应用 |
| CN116768983A (zh) * | 2020-10-28 | 2023-09-19 | 王立良 | 一种用于慢性乙型肝炎预防和/或治疗的蛋白、编码基因、重组腺相关病毒及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849987A (en) * | 1992-06-02 | 1998-12-15 | Yeda Research And Development Co. Ltd. | Animal model for hepatitis virus infection |
-
2001
- 2001-09-13 IL IL14544001A patent/IL145440A0/xx unknown
-
2002
- 2002-09-09 WO PCT/IL2002/000744 patent/WO2003022880A2/en not_active Ceased
- 2002-09-09 EP EP02765319A patent/EP1427827A2/en not_active Withdrawn
- 2002-09-09 JP JP2003526952A patent/JP2005510211A/ja not_active Abandoned
- 2002-09-09 CN CNA028180828A patent/CN1555415A/zh active Pending
- 2002-09-09 US US10/488,269 patent/US20050069865A1/en not_active Abandoned
- 2002-09-09 CA CA002460509A patent/CA2460509A1/en not_active Abandoned
- 2002-09-09 KR KR10-2004-7003715A patent/KR20040041612A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsukiyama-Kohara et al. | Antigenicities of group I and II hepatitis C virus polypeptides—molecular basis of diagnosis | |
| RU2130969C1 (ru) | Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека | |
| RU2001101869A (ru) | Частицы белков оболочки HCV: применение для вакцинации | |
| ES2207633T3 (es) | Secuencias genomicas del vhc para diagnostico y tratamiento. | |
| RU2148587C1 (ru) | Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа | |
| EP0698216B2 (en) | Methods of typing hepatitis c virus and reagents for use therein | |
| ES2212796T3 (es) | Mutantes del virus de la hepatitis b, reactivos y metodos de deteccion. | |
| JPH07503614A (ja) | Ｈｃｖ蛋白のための哺乳動物発現システム | |
| JP2005510211A5 (https=) | ||
| ES2143996T5 (es) | Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv. | |
| US6692751B1 (en) | Methods and systems for producing recombinant viral antigens | |
| JP3061258B2 (ja) | 非ａ非ｂ非ｃ非ｄ非ｅ型肝炎試薬及びそれらの使用方法 | |
| KR20020008172A (ko) | Ττ바이러스 서열 유래의 펩티드 및 ττ바이러스에결합하는 단일특이적 항체 | |
| Lorenzo et al. | Expression and immunological evaluation of the Escherichia coli‐derived hepatitis C virus envelope E1 protein | |
| Zhang et al. | Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction | |
| WO2003097814A3 (en) | Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins | |
| JP2554612B2 (ja) | 相補肝炎ａウイルスゲノムを含有している雑種ｄｎａの調製法、該雑種ｄｎａ、これを含有するプラスミドベクタ−、雑種ｄｎａによって発現されたウイルス特異蛋白質およびこれから調製され、これらを含有するワクチン | |
| Bukh et al. | Diagnostic and clinical implications of the different genotypes of hepatitis C virus | |
| Chang et al. | Artificial NS4 mosaic antigen of hepatitis C virus | |
| US5866139A (en) | Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications | |
| JP2005510211A (ja) | 合成ｈｃｖ外被蛋白質及びワクチンのためのその使用 | |
| JPS58150518A (ja) | Ｂ型肝炎ウイルスのための免疫学的組成物及び方法 | |
| Yoon et al. | Molecular typing of hepatitis C virus genome from sera and liver tissues of patients with anti-HCV positive chronic liver disease | |
| KR0158434B1 (ko) | C형 간염 바이러스에 대한 항체 검출 및 면역원으로 유용한 합성 펩타이드 | |
| JPH11124398A (ja) | Ｃ型肝炎ウイルス由来の抗原ペプチドとそれを用いる抗体検査薬 |